Log In
BCIQ
Print this Print this
 

briciclib (ON 013105)

  Manage Alerts
Collapse Summary General Information
Company Onconova Therapeutics Inc.
DescriptionAnticancer drug that targets eukaryotic translation initiation factor 4E (elF4E) to drive cancer cells into apoptosis following mitotic arrest
Molecular Target Eukaryotic translation initiation factor 4E (eIF4E)
Mechanism of ActionCyclin D1 inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat advanced solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today